Yoshirô Matsumoto

Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.

Jun Itakura, Toshiyuki Ishiwata, Helmut Friess et al. · PubMed · 1997 · 271 citations

Immunology, Pathology, Total Rna +20

Cumulative Results in 57 Institutions in Japan

A Nakase, Yoshirô Matsumoto, Kôtarô Uchida et al. · Annals of Surgery · 1977 · 235 citations · Full text

Status of c‐<i>erb</i>B‐2 in gastric adenocarcinoma: A comparative study of immunohistochemistry, fluorescence <i>in situ</i> hybridization and enzyme‐linked immuno‐sorbent assay

Takuo Takehana, Kazuyoshi Kunitomo, Koji Kono et al. · International Journal of Cancer · 2002 · 196 citations · Full text

Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.

Toshiyuki Kusama, Mutsuko Mukai, Teruo Iwasaki et al. · PubMed · 2001 · 187 citations

Tumor Biology, Hmg-coa Reductase Inhibitors, Oncology +15

The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection

Hideo Ozaki, Takehisa Hiraoka, Ryuji Mizumoto et al. · Surgery Today · 1999 · 169 citations

Surgical Oncology, Pancreatic Cancer, Gastrointestinal Oncology +7